Catalog Number 08033668001 |
Device Problems
False Positive Result (1227); Non Reproducible Results (4029)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/09/2023 |
Event Type
malfunction
|
Event Description
|
A customer from ireland alleged discrepant results for 4 patient samples using the ventana anti-mlh1 (m1) mouse monoclonal primary antibody.The first two samples were run the week of (b)(6) 2023: two alleged samples initially produced positive staining results which were reported to medical personnel.The next two samples were run the week of (b)(6) 2023: the staining results for the other two alleged samples were reported to medical personnel as "uninterpretable." the hypermethylation testing results for all 4 patient samples indicated that the mlh-1 staining should have been negative.The customer stated the on-slide controls stained as expected.To date, no harm or injury is alleged.
|
|
Manufacturer Narrative
|
The investigation is ongoing.A supplemental mdr will be filed upon completion of the investigation.The customer issue has been alleged on the mlh1 (m1) mm pab-us export (catalog no: 08033668001; udi: (b)(4)) which is equivalent to the us kit; mlh1 (m1) mouse monoclonal pab us (catalog no: 07862237001; udi: (b)(4)).
|
|
Manufacturer Narrative
|
The device code was updated.The customer's slide images were requested for review but were not provided.A review of the mlh1 protocol report from the customer¿s host computer indicates that the customer was not using the package insert recommended protocol when the affected slides were stained.The customer decreased the antigen retrieval time and decreased the primary antibody incubation time.Product labeling states: "this antibody has been optimized for specific incubation times, but the user must validate results obtained with this reagent.The effect of varying time and temperature of the antigen retrieval (cell conditioning) and antibody incubation from the recommended staining protocol may result in sub optimal staining and false mmr results.It is strongly recommended not to deviate from the recommended staining protocol.Appropriate controls should be employed and documented.Users who deviate from the listed protocol must accept responsibility for interpretation of patient results." the investigation did not identify a product problem.
|
|
Search Alerts/Recalls
|